Industrial partners
CR2O
CR2O is an international research organization that specializes in the strategic planning and implementation of clinical development programs.
As part of a collaboration with the DZIF, CR2O is supporting the clinical development of a vaccine against the MERS coronavirus. The aim of the collaboration is to continue to guide the vaccine, which was developed at the DZIF up to phase I, through the necessary clinical trial stages and prepare it for use in humans.